Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
1.280
-0.020 (-1.54%)
At close: May 11, 2026, 4:00 PM EDT
1.300
+0.020 (1.56%)
After-hours: May 11, 2026, 6:40 PM EDT

Filana Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
86.5795.5128.57121.14201.02233.44
Cash & Short-Term Investments
86.5795.5128.57121.14201.02233.44
Cash Growth
-26.21%-25.72%6.14%-39.74%-13.89%149.65%
Other Current Assets
1.392.217.968.510.2111.05
Total Current Assets
87.9697.71136.53129.63211.23244.48
Net Property, Plant & Equipment
20.420.652121.8522.9920.83
Other Intangible Assets
---0.180.621.08
Other Long-Term Assets
-----0.4
Total Assets
108.37118.36157.53151.66234.83266.78
Accounts Payable
39.1941.657.6510.574.027.13
Accrued Expenses
0.851.993.83.242.454.68
Current Portion of Leases
----0.10.1
Other Current Liabilities
0.080.20.30.390.490.63
Total Current Liabilities
40.1243.8311.7514.27.0612.53
Long-Term Leases
----0.040.14
Other Long-Term Liabilities
0.110.120.08-0.20.19
Total Long-Term Liabilities
0.110.120.08-0.230.33
Total Liabilities
40.2343.9511.8314.27.312.87
Common Stock
0.050.050.050.040.040.04
Additional Paid-in Capital
574.51570.44550.77518.2511.05461.18
Retained Earnings
-506.42-496.08-405.11-380.77-283.55-207.31
Shareholders' Equity
68.1474.4145.7137.47227.54253.92
Total Liabilities & Equity
108.37118.36157.53151.66234.83266.78
Total Debt
-0000.140.24
Net Cash (Debt)
86.5795.5128.57121.14200.88233.2
Net Cash Growth
-9.35%-25.72%6.14%-39.70%-13.86%150.18%
Net Cash Per Share
1.791.982.762.895.005.92
Book Value
68.1474.4145.7137.47227.54253.92
Book Value Per Share
1.411.543.133.285.666.44
Tangible Book Value
68.1474.4145.7137.29226.92252.84
Tangible Book Value Per Share
1.411.543.133.275.646.42
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q